Raising NAD+ With Nicotinamide Riboside Resolved Social Deficits in Autism Mouse Model

An autism model developed in male mice supplemented with nicotinamide riboside (NR) was found to have restored levels of the neurotransmitter oxytocin and improved social behavior.

Phase 3 Clinical Trial Demonstrates Combined Metabolic Activators (CMAs) Accelerates Recovery in Mild-to-Moderate COVID-19

Results of a phase 3, double-blind, placebo-controlled trial assessing whether a mixture of Combined Metabolic Activators (CMAs) targeted at mitochondrial function, could improve metabolic function...

Nicotinamide Riboside May Offer Unique Protection Against Endothelial Inflammation

A new study shows that while both nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) can help protect against blood-vessel inflammation by raising NAD+, NR may be the more direct and ...

All Eyes on NAD+ as Preclinical Study Demonstrates Protection Against Light-Induced Retinal Degeneration

A recent study found that raising NAD+ levels in a mouse model could protect the survival and function of retinal cells, the cells responsible for sight, against damaging UV light.

Combined Metabolic Activators Therapy Reduces Liver Fat by 10% In Nonalcoholic Fatty Liver Disease Patients

A recent phase 2 clinical trial published on Cell Press Sneak Peek, a preprint publication website for papers under review by Cell Press Journals, found that a novel combined metabolic cofactor sup...

Nicotinamide Riboside Supplementation Improves Ataxia Scores and Increases Antibody Levels in Ataxia Telangiectasia Patients

Ataxia telangiectasia (AT) is a rare, inherited neurodegenerative disorder characterized by cerebellar degeneration, immunodeficiency, and cancer predisposition. Previous preclinical research has s...

Research Found an Association Between Muscle Health and NAD+ Abundance in Humans

Aging results in a gradual loss of skeletal muscle function over time. Sarcopenia, the progressive loss of skeletal muscle mass, strength, and performance with age, is one of the critical causes of...

First-of-its-kind Agricultural Study Finds In Ovo Feeding of Nicotinamide Riboside Affects Poultry Broiler Pectoralis Major Muscle Development

A study published in Translational Animal Science finds that in ovo nicotinamide riboside (NR) injections increased chick pectoralis major (PM) muscle weight, length, width, and depth – a result wh...

Nicotinamide Riboside Helps Protect Nerve Fibers During Chemotherapy and Enhances Paclitaxel’s Tumor-suppressing Effects in Animal Models

Raising NAD+ levels with nicotinamide riboside has been shown, in animal models, to reduce pain resulting from the cancer treating drug therapy paclitaxel. When administered to rodents in combinati...

New Phase 2 Clinical in COVID-19 Patients Finds Hydroxychloroquine (HCQ) Plus Nutritional Protocol Including Nicotinamide Riboside Significantly Improved Recovery Time Vs. HCQ Alone

On the heels of two previously published preclinical studies investigating the effect of viral infection on NAD+ levels, new clinical research in 93 mild-to-moderate COVID-19 infected patients is n...

NAD+ May Modulate Inflammation in End-Stage Heart Failure Patients

Raising NAD+ levels with the precursor Nicotinamide Riboside (NR) was found to reduce markers of inflammation in the blood from a small group of Stage D heart failure (HF) patients.

Elderly Patients with Heart Failure Have Lower NAD+ Levels

A new study published in Experimental Gerontology found that among 170 blood donors, elderly patients with heart failure had the lowest NAD+ levels, which suggests a role for NAD+ precursors in sup...

Combined Metabolic Activators (CMAs) Improves Cognitive Functions in Alzheimer’s Disease

Results of a new phase 2 clinical study assessing whether administration of a mixture of Combined Metabolic Activators (CMAs) including NAD+ precursor nicotinamide riboside (NR) could treat Alzheim...

Combined Metabolic Activators (CMAs) Improve Cognitive Functions without Altering Motor Scores in Parkinson's Disease

A new study assessing whether administration of a mixture of Combined Metabolic Activators (CMAs), including NAD+ precursor nicotinamide riboside (NR), could treat Parkinson’s disease patients, is ...

Re-Balancing NAD+ Metabolism Blunts the Impact of Telomere Dysfunction in Human Cells, Mice

A recent study published in The European Molecular Biology Organization Journal, conducted by investigators at the National Institute on Aging (NIA) and the National Cancer Institute (NCI), both di...

Inflammation: A Double Edge Sword in Immunity

The latest research suggests NAD+ may play a central role in regulating inflammation for an effective—but targeted—immune response to dangerous pathogens such as the Coronavirus.

Increasing Nicotinamide Adenine Dinucleotide (NAD+) with Nicotinamide Riboside (NR) Reduced Neurodegeneration, and Increased Lifespan in Preclinical Model

The human body is composed of cells in the trillions. Each cell relies on a resource molecule called NAD+ for the generation of energy we know as ATP. This energy helps cells perform their unique f...

First Study To Measure Postpartum NAD Levels Is Out Now

New moms don’t need scientists to tell them that postpartum is stressful. As if bringing a new life into the world isn’t hard enough, moms have to adjust to an ever-changing body and new identity w...

Evaluating Scientific Studies: Nicotinamide Riboside and Physical Performance

In a paper published in the Journal of the International Society of Sports Nutrition, researchers at Aristotle University of Thessaloniki in Serres, Greece reported that rats who received NR tended...

Early Clinical Research Shows NR May Lower Blood Pressure to Support Cardiovascular Health

Over the last several years there has been an influx of research started on nicotinamide riboside (NR) due to its unique mechanism for raising levels of the coveted compound nicotinamide adenine di...